LakeShore Cash from 2010 to 2025

LSBPW Stock   0.06  0.02  54.49%   
LakeShore Biopharma Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 201.6 M in 2025. Cash is the total amount of money in the form of currency that LakeShore Biopharma Co, has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-12-31
Previous Quarter
221.7 M
Current Value
201.6 M
Quarterly Volatility
111.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 1.07, Dividend Yield of 0.0 or PTB Ratio of 1.05. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Latest LakeShore Biopharma's Cash Growth Pattern

Below is the plot of the Cash of LakeShore Biopharma Co, over the last few years. Cash refers to the most liquid asset of LakeShore Biopharma Co,, which is listed under current asset account on LakeShore Biopharma Co, balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from LakeShore Biopharma customers. The amounts must be unrestricted with restricted cash listed in a different LakeShore Biopharma account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. LakeShore Biopharma's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

LakeShore Cash Regression Statistics

Arithmetic Mean333,478,052
Geometric Mean239,346,467
Coefficient Of Variation33.32
Mean Deviation82,924,920
Median390,457,084
Standard Deviation111,102,529
Sample Variance12343.8T
Range389.6M
R-Value(0.60)
Mean Square Error8463.1T
R-Squared0.36
Significance0.01
Slope(14,003,519)
Total Sum of Squares185156.6T

LakeShore Cash History

2025201.6 M
2024221.7 M
2023246.4 M
2022370.1 M
2021885.2 K

Other Fundumenentals of LakeShore Biopharma Co,

LakeShore Biopharma Cash component correlations

About LakeShore Biopharma Financial Statements

LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash221.7 M201.6 M
Cash And Short Term Investments221.7 M201.6 M
Change In Cash-111.4 M-105.9 M
Free Cash Flow-390.4 M-409.9 M
Begin Period Cash Flow425.9 M284.3 M
Other Cashflows From Financing Activities-39.8 M-37.8 M
Other Non Cash Items176.8 M185.7 M
Total Cash From Operating Activities-265.7 M-279 M
Total Cash From Financing Activities184.7 M292.7 M
End Period Cash Flow221.9 M201.7 M
Free Cash Flow Yield(0.70)(0.66)
Operating Cash Flow Per Share(31.75)(30.17)
Free Cash Flow Per Share(36.51)(34.69)
Cash Per Share 20.74  21.77 
Capex To Operating Cash Flow(0.13)(0.14)
EV To Operating Cash Flow(2.25)(2.36)
EV To Free Cash Flow(1.96)(2.06)
Price To Operating Cash Flows Ratio(1.71)(1.79)
Price To Free Cash Flows Ratio(1.49)(1.56)
Cash Ratio 0.35  0.34 
Cash Conversion Cycle 811.13  714.57 
Operating Cash Flow Sales Ratio(0.46)(0.49)
Free Cash Flow Operating Cash Flow Ratio 1.32  1.26 
Cash Flow Coverage Ratios(0.63)(0.66)
Price Cash Flow Ratio(1.71)(1.79)
Cash Flow To Debt Ratio(0.63)(0.66)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.